A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.
San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...
A Tucson rescuer trapped a friendly tomcat during TNR work—now Uncle Potato is safe indoors, getting care and drawing huge adoption interest.
Everything you need to know - Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug ...
More than half of the world's pet cats are overweight, experts estimate, and soon, these chubby felines may be treated with a ...
A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...
A new drug by pharmaceutical giant Eli Lilly rivaling Ozempic and Wegovy could lead to 'significantly' more weight loss after just one year, a trial showcasing initial results has suggested.